Giudice, Elena
 Distribuzione geografica
Continente #
NA - Nord America 132
EU - Europa 70
AS - Asia 13
AF - Africa 1
Totale 216
Nazione #
US - Stati Uniti d'America 132
IT - Italia 29
IE - Irlanda 17
SE - Svezia 9
FR - Francia 6
CN - Cina 4
KR - Corea 4
GB - Regno Unito 3
NL - Olanda 3
SG - Singapore 2
AT - Austria 1
CI - Costa d'Avorio 1
ES - Italia 1
FI - Finlandia 1
IN - India 1
IR - Iran 1
JP - Giappone 1
Totale 216
Città #
Ashburn 32
Chandler 27
Dublin 17
Rome 10
New York 8
San Mateo 6
Washington 6
Beijing 4
Milan 4
Amsterdam 3
Asti 3
Boston 3
Busto Arsizio 3
Jeju City 3
Marseille 3
Princeton 3
Bari 2
Guidonia Montecelio 2
Nave 2
Osimo 2
Paris 2
Abidjan 1
Andover 1
Cambridge 1
Lappeenranta 1
Leawood 1
Madrid 1
Mountain View 1
Norwalk 1
Redwood City 1
Singapore 1
Suyeong-gu 1
Tappahannock 1
Tokyo 1
Vienna 1
York 1
Zanjan 1
Totale 161
Nome #
Pembrolizumab for advanced cervical cancer: safety and efficacy 35
Bevacizumab as maintenance treatment in BRCA mutated patients with advanced ovarian cancer: A large, retrospective, multicenter case-control study 33
Evolution of Clinical Trials in Ovarian Cancer Management over the Past 20 Years: Never Settle Down, Always Go beyond 26
Survival outcomes in patients with BRCA mutated, variant of unknown significance, and wild type ovarian cancer treated with PARP inhibitors 25
Recent progress in the use of pharmacotherapy for endometrial cancer 20
PARP Inhibitors Resistance: Mechanisms and Perspectives 20
Combining PARP inhibition and immune checkpoint blockade in ovarian cancer patients: a new perspective on the horizon? 19
Preclinical and Clinical Evidence of Lurbinectedin in Ovarian Cancer: Current Status and Future Perspectives 14
Advanced and recurrent endometrial cancer: State of the art and future perspectives 14
Survival outcomes in patients with BRCA mutated, variant of unknown significance, and wild type ovarian cancer treated with PARP inhibitors 11
Management of stage III and IVa uterine cancer 10
Survival outcomes in patients with BRCA mutated, variant of unknown significance, and wild type ovarian cancer treated with PARP inhibitors 4
Genome tumor profiling in endometrial cancer and clinical relevance in endometrial cancer management: A retrospective single-center experience 1
Totale 232
Categoria #
all - tutte 1.673
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.673


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212 0 0 0 0 0 0 1 0 0 0 1 0
2021/202225 0 0 0 5 0 0 1 7 2 1 2 7
2022/202384 6 9 2 9 2 8 4 3 6 9 19 7
2023/2024121 4 25 17 16 4 21 19 3 5 5 2 0
Totale 232